BioMimetic Therapeutics' (BMTI) shares rose after an analyst at AG Edwards increased his price target on the stock. Pharmaceuticals analyst Jan Wald now sees a 2006 loss of $1.27 a share on sales of $3.6 million in 2006, improved from his previous expectations of a $1.95 loss per share on sales of $3.5 million. For 2007, he expects a loss of $1.33 on sales of $5.7 million, up from a $2.42 loss on sales of $5.9 million. Accordingly, he increased his price target on the stock to $18 from $11. BioMimetic shares were up 39 cents, or 3.9%, to $11.90.
Among other health care stocks rising Friday were PDL BioPharma (PDLI), up 2.6% to $23.09, Encysive Pharmaceuticals (ENCY), gaining 8.9% to $6.87, Labopharm (DDSS), 3.7% higher to $6.10, Iomai (IOMI), whose shares were boosted 5.9% to $5.17 and Sangamo Biosciences (SGMO), up 5.1% to $7.90.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment